Rodman & Renshaw Hikes Price Target On Adventrx Pharmaceuticals (ANX) to $16
Tweet Send to a FriendGet Alerts ANX Hot Sheet
Price: $0.73 --0%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade ANX Now!
Rodman & Renshaw raised their price target on Adventrx Pharmaceuticals (NYSE: ANX) from $4.50 to $16 while maintaining their Market Outperform rating.
Shares are on the move following the price target hike. Last trading up 9.7% to $2.60.
For more ratings news on Adventrx Pharmaceuticals click here and for the rating history of Adventrx Pharmaceuticals click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares are on the move following the price target hike. Last trading up 9.7% to $2.60.
For more ratings news on Adventrx Pharmaceuticals click here and for the rating history of Adventrx Pharmaceuticals click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- The ExOne Company (XONE) Metal Opportunity to Keep Stock Going - FBR
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Rodman & RenshawComments
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
Re: Treasurer
allengodwinbis on Aug 29, 2011 02:05 AMMark as Spam | Reply to this comment
Thanks for sharing this information.
_______
Allen
Anchor Text